Tawasil, Alkhaisal M.
HRN: 21-39-86 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2022
AMPICILLIN 250MG (VIAL)
11/29/2022
12/06/2022
IVT
225 Mg
6 Hrs
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes